Schizandrin B
CAS No. 61281-37-6
Schizandrin B( Wuweizisu B )
Catalog No. M15307 CAS No. 61281-37-6
Schisandrin B(Wuweizisu-B) is a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 82 | In Stock |
|
| 5MG | 75 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 231 | In Stock |
|
| 50MG | 405 | In Stock |
|
| 100MG | 569 | In Stock |
|
| 200MG | 806 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSchizandrin B
-
NoteResearch use only, not for human use.
-
Brief DescriptionSchisandrin B(Wuweizisu-B) is a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae.
-
DescriptionSchisandrin B(Wuweizisu-B) is a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae, has been shown to produce antioxidant effect on rodent liver and heart.
-
In VitroReal Time qPCR Cell Line:lymphocyte Concentration:10-50 μM Incubation Time:4 h Result:Increase in relative mRNA copy number of Nrf2, HO-1, TrxR1, and GCLC.Increased basal ROS levels and decreased GSH/GSSG ratio.
-
In VivoAnimal Model:Mice endotoxic shock model Dosage:80 mg/kg.Administration:Intraperitoneally injected (i.p.), single dose.Result:Decreased proliferation and secretion of the proinflammatory cytokines IL-2, IL-6, and IFN-g .
-
SynonymsWuweizisu B
-
PathwayCell Cycle/DNA Damage
-
TargetATM/ATR
-
RecptorATR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number61281-37-6
-
Formula Weight400.46
-
Molecular FormulaC23H28O6
-
Purity>98% (HPLC)
-
SolubilityEthanol: 10 mg/mL (24.97 mM); DMSO: 80 mg/mL (199.77 mM)
-
SMILESCOC1=C(OC)C(OC)=C2C(CC(C)C(C)CC3=CC4=C(OCO4)C(OC)=C23)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bunel V, et al. J Appl Toxicol. 2014 Dec;34(12):1311-9.
molnova catalog
related products
-
CBP-93872
A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint.
-
AZ-31
A potent, highly selective and orally active ATM inhibitor with enzyme IC50 of <1.2 nM, cell IC50 of 46 nM.
-
BAY-1895344
BAY-1895344 is a potent, selective, orally active ATR inhibitor with low-nanomolar potency; potently inhibits the proliferation of a broad spectrum of human tumor cell lines with mean IC50 of 78 nM; inhibits hydroxyurea-induced H2AX phosphorylation, exhibits strong in vivo anti-tumor efficacy in monotherapy in a variety of xenograft models.Blood Cancer,Phase 1 Clinical
Cart
sales@molnova.com